Change in NLR and Survival Among Advanced Lung Cancer Patients Receiving ICIs With Immunomodulator

NCT04352335 · clinicaltrials.gov ↗
COMPLETED
Status
53
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Chung Shan Medical University